Health Expanding PARP Inhibitor Benefits in Advanced Pancreatic Cancer Jason Junior May 12, 2021 Maintenance therapy with a PARP inhibitor demonstrated activity in mutated advanced pancreatic cancer beyond germline BRCA variants, results of a…
